Phantom study on three-dimensional target volume delineation by PET/CT-based auto-contouring.

OBJECTIVE The aim of this study was to determine an appropriate threshold value for delineation of the target volume in PET/CT and to investigate whether we could delineate a target volume by phantom studies. METHODS A phantom consisted of six spheres (phi 10-37 mm) filled with 18F solution. Data acquisition was performed PET/CT in non-motion and motion status with high 18F solution and in non-motion status with low 18F solution. In non-motion phantom experiments, we determined two types of threshold value, an absolute SUV (T(SUV)) and a percentage of the maximum SUV (T%). Delineation using threshold values was applied for all spheres and for selected large spheres (a diameter of 22 mm or larger). In motion phantom experiments, data acquisition was performed in a static mode (sPET) and a gated mode (gPET). CT scanning was performed with helical CT (HCT) and 4-dimensional CT (4DCT). RESULTS The appropriate threshold values were aT% = 27% and aT(SUV) = 2.4 for all spheres, and sT% = 30% and sT(SUV) = 4.3 for selected spheres. For all spheres in sPET/HCT in motion, the delineated volumes were 84%-129% by the aT% and 34%-127% by the aT(SUV). In gPET/4DCT in motion, the delineated volumes were 94-103% by the aT% and 51-131% by the aT(SUV). For low radioactivity spheres, the delineated volumes were all underestimated. CONCLUSION A threshold value of T% = 27% was proposed for auto-contouring of lung tumors. Our results also suggested that the respiratory gated data acquisition should be performed in both PET and CT for target volume delineation.

[1]  Sigrid Stroobants,et al.  Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Ling,et al.  Effect of respiratory gating on quantifying PET images of lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  Lale Kostakoglu,et al.  Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck. , 2008, International journal of radiation oncology, biology, physics.

[4]  Kazutaka Hayashi,et al.  Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma , 2002, Annals of nuclear medicine.

[5]  H. Keller,et al.  Quantitative PET Comparing Gated with Nongated Acquisitions Using a NEMA Phantom with Respiratory-Simulated Motion , 2007, Journal of Nuclear Medicine Technology.

[6]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[7]  Douglas K Owens,et al.  Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. , 2003, Annals of internal medicine.

[8]  A. Dirksen,et al.  Preoperative staging of lung cancer with combined PET-CT. , 2009, The New England journal of medicine.

[9]  Importance of gated CT acquisition for the quantitative improvement of the gated PET/CT in moving phantom , 2010, Annals of nuclear medicine.

[10]  Karin Haustermans,et al.  PET-based treatment planning in radiotherapy: a new standard? , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Di Yan,et al.  Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.

[12]  Sasa Mutic,et al.  18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Sasaki,et al.  Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung , 2001, Annals of nuclear medicine.

[15]  Otto S Hoekstra,et al.  The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  E Yorke,et al.  Four-dimensional (4D) PET/CT imaging of the thorax. , 2004, Medical physics.

[17]  Y. Nishimura,et al.  Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system , 2008, Annals of nuclear medicine.

[18]  Y. Nishimura,et al.  Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity. , 2010, International journal of radiation oncology, biology, physics.

[19]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[20]  L. John,et al.  Quality of life in patients receiving radiation therapy for non-small cell lung cancer. , 2001, Oncology nursing forum.

[21]  C B Caldwell,et al.  Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.

[22]  A. Pevsner,et al.  The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[24]  G. Friedel,et al.  Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Anil Sethi,et al.  Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. , 2007, International journal of radiation oncology, biology, physics.

[26]  Koichiro Abe,et al.  A simple table lookup method for PET/CT partial volume correction using a point-spread function in diagnosing lymph node metastasis , 2010, Annals of nuclear medicine.